Evidence map›Paper›PMID 36750073›Full record

ArticleSalud publica de Mexico2023

Cocirculation and replacement of SARS-CoV-2 variants in crowded settings and marginalized populations along the US-Mexico border.

Antoine Chaillon, Ietza Bojorquez, Jaime Sepúlveda, Alicia Yolanda Harvey-Vera, M Gudelia Rangel, Britt Skaathun, Sanjay R Mehta, Caroline Ignacio, Magali Porrachia, Davey M Smith and 1 more

Open access · diamondAbstract read
In one paragraph

Article in Salud publica de Mexico, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Antoine ChaillonDivision of Infectious Diseases and Global Public Health, University of California San Diego. San Diego, United States. achaillon@health.ucsd.edu.
Ietza BojorquezDepartamento de Estudios de Población, El Colegio de la Frontera Norte. Tijuana, Mexico. ietzabch@colef.mx.
Jaime SepúlvedaInstitute for Global Health Sciences, University of California. San Francisco, United States. Jaime.Sepulveda@ucsf.edu.
Alicia Yolanda Harvey-VeraDivision of Infectious Diseases and Global Public Health, University of California San Diego. San Diego, United States/Facultad de Medicina, Universidad de Xochicalco. Tijuana, Mexico/United States-Mexico Border Health Commission. Tijuana, Mexico. alvera@health.ucsd.edu.
M Gudelia RangelDepartamento de Estudios de Población, El Colegio de la Frontera Norte/United States-Mexico Border Health Commission. Tijuana, Mexico. grangel@colef.mx.
Britt SkaathunDivision of Infectious Diseases and Global Public Health, University of California San Diego. San Diego, United States. bskaathun@health.ucsd.edu.
Sanjay R MehtaDivision of Infectious Diseases and Global Public Health, University of California San Diego/Veterans Affairs Health System. San Diego, United States. srmehta@health.ucsd.edu.
Caroline IgnacioDivision of Infectious Diseases and Global Public Health, University of California San Diego. San Diego, United States. cignacio@health.ucsd.edu.
Magali PorrachiaDivision of Infectious Diseases and Global Public Health, University of California San Diego/Veterans Affairs Health System. San Diego, United States. mporrachia@health.ucsd.edu.
Davey M SmithDivision of Infectious Diseases and Global Public Health, University of California San Diego/Veterans Affairs Health System. San Diego, United States. d13smith@health.ucsd.edu.
Steffanie A StrathdeeDivision of Infectious Diseases and Global Public Health, University of California San Diego. San Diego, United States. sstrathdee@health.ucsd.edu.
University of California System · USUniversity of California, San Diego · USEl Colegio de la Frontera Norte · MXUniversity of California, San Francisco · US

Funding

UC San Diego Clinical and Translational Research InstituteUL1TR001442 · NCATS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FIRESTEIN, GARY S, HOGARTH, MICHAEL · 2015 to 2024
$88.3M
VirologyP30AI036214 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI David Mitchell Smith · 1994 to 2026
$78.4M
Ethno-epidemiology of HCV, HIV and Overdose associated with Drug Marketsand Drug TourismR01DA049644 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI STRATHDEE, STEFFANIE A. · 2020 to 2024
$8.2M
Brain Myeloid Cells are Sources of HIV-associated Damage and Viral DispersalR01DA055491 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CHAILLON, ANTOINE · 2021 to 2025
$3.6M
NCATS NIH HHS UL1 TR001442NIAID NIH HHS P30 AI036214NIDA NIH HHS R01 DA049644NIDA NIH HHS R01 DA055491
6 · The paper itself

Abstract

objectiveTo interrogate the circulating SARS-CoV-2 lin-eages and recombinant variants in persons living in migrant shelters and persons who inject drugs (PWID). MATERIALS AND

methodsWe combined data from two studies with marginalized populations (migrants in shelters and persons who inject drugs) in Tijuana, Mexico. SARS-CoV-2 variants were identified on nasal swabs specimens and compared to publicly available genomes sampled in Mexico and California.

resultsAll but 2 of the 10 lineages identified were predomi-nantly detected in North and Central America. Discrepan-cies between migrants and PWID can be explained by the temporal emergence and short time span of most of these lineages in the region.

conclusionThe results illustrate the temporo-spatial structure for SARS-CoV-2 lineage dispersal and the potential co-circulation of multiple lineages in high-risk populations with close social contacts. These conditions create the potential for recombination to take place in the California-Baja California border.

Indexed as

COVID-19Drug UsersSubstance Abuse, IntravenousHumansMexicoSARS-CoV-2

Identifiers

PMID36750073
PMCPMC10291843
OpenAlexW4311835971

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.